Welcome to a monthly bonus episode. I sat down with Dr. Amir Kalali, the co-chair of the Decentralized Trials & Research Alliance (DTRA) – a clinical research coalition of the most influential companies in the field to talk about decentralized research and collaborating for our success as an industry.
2:35 – From CRO to CNS Summit
10:30 – Ramping up DTRA
12:29 – The Ramp of Decentralized Trials
15:50 – What will stick after the pandemic?
19:28 – How different are decentralized trials really?
22:42 – Technology traps and Hybrid Trials
25:12 – How are trust networks changing with decentralized trials?
29:09 – What is the roll of DTRA in the industry?
33:28 – Ecosystems are interconnected, how can we partner within the clinical research/pharma ecosystem?
36:10 – What is the future of the DTRA?
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.